Cryo Save Group NV: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Cryo Save Group NV announces acquisition of commercial activities of Salveo Biotechnology
Cryo Save Group NV:Says it has signed an agreement to acquire all assets that are exclusively related to the distribution and commercial activities of the umbilical cord blood and umbilical cord tissue cryopreservation business of Salveo Biotechnology S.A., Switzerland and its subsidiaries, effective as of Jan 1, 2014.Says the payment for the transaction consists of 485,597 Cryo-Save Group N.V. shares plus an additional amount in cash, payable in June 2014.
Latest Developments for Cryo Save Group NV
- Share this
- Digg this